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ABSTRACT
Background: Gadolinium-enhanced magnetic resonance imaging (MRI) can be used to observe the pro-
gression of cerebral infarction, which sometimes mimics malignant brain tumors. While the β2-
microglobulin (β2MG) level in blood plasma or cerebrospinal fluid (CSF) is useful for the diagnosis of
malignant tumors or degenerative diseases, these results may create confusion regarding a definitive diagno-
sis, because it is not a specific marker. We present a rare case of symptomatic developmental venous anom-
aly (DVA), accompanied by transient, irregular, enhanced cerebral lesions and elevated β2MG in the CSF.
Case Description: A 56-year-old woman developed dysarthria and underwent MRI, which revealed a right
frontal hyperintense area around a previous lesion on diffusion-weighted imaging (DWI). She was treated
based on the tentative diagnosis of an ischemic cerebrovascular event, and symptoms subsided in 3 days.
MRI on day 7 revealed an enlargement of the hyperintense area on DWI. Post-gadolinium MRI showed mul-
tiple, enhanced patchy areas in the right frontal lobe and an abnormally large vein connected to dilated
medullary venules, indicating DVA. Magnetic resonance angiography showed no stenosis or arterial occlu-
sion. The β2MG level in the CSF was elevated at 2,061 μg/l, and a differential diagnosis from malignant
tumor was required. However, MRI on day 23 revealed total disappearance of the enhanced lesions and a
decrease in the high intensity area on DWI. Considering the clinical course, the DVA was symptomatic
because of the perfusion disturbance.
Conclusion: Careful evaluation is necessary when considering the associated pathologies and potential
complications of DVA if detected near a gadolinium-enhanced lesion.
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INTRODUCTION
Developmental venous anomaly (DVA) refers to con-
verging, dilated medullary veins that drain centripetally
and radially into a transcerebral collector that opens into
either superficial subcortical veins or deep pial veins9).
DVA is a congenital venous drainage malformation that
occurs sporadically as a result of intrauterine ischemia,
leading to the aberrant development of the venous archi-
tecture. The incidence of this condition has been
reported to be as high as 2.5%, as indicated by post-
mortem autopsies16). DVA accounts for nearly 50% of all
cerebral vascular malformations that are discovered in
magnetic resonance imaging (MRI) studies5). Most of
these lesions are benign neurovascular malformations
without accompanying symptoms. When DVA becomes
symptomatic, mechanical, flow-related, or idiopathic
mechanisms can underlie the condition, and flow-related
causes account for approximately 70% of symptomatic
cases14). Hemorrhages and infarctions are common mor-
phological changes induced by DVA.
The MRI findings differ slightly depending on the time
course and etiology of DVA. Diffusion-weighted imaging
(DWI) and an apparent diffusion coefficient (ADC)
assessment in MRI facilitate the diagnosis of the acute
phase of cerebral infarction22); whereas, ischemic lesions
can often be enhanced by gadolinium, as has been found
with brain tumors, if the blood-brain barrier (BBB) is
impaired15). In such situations, the diagnosis of DVA
becomes complicated if other laboratory findings suggest
the presence of a brain tumor. We present a rare case of
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symptomatic DVA, accompanied by transient, enhanced
lesions in the cerebrum and increased β2-microglobulin
(β2MG) in the cerebrospinal fluid (CSF).
CASE PRESENTATION
A 56-year-old woman had been taking 100 mg/day of
aspirin for the last 6 years, because of a right frontal
white matter lesion in the right frontal lobe that had
been found during a voluntary brain MRI check-up. On
the day of onset, the patient was aware of mild dysarthria
and visited a primary care hospital. She had mild dys-
arthria during the consultation, and the MRI showed a
hyperintense lesion in the right frontal lobe near an old
lesion on DWI and in the fluid-attenuated inversion
recovery (FLAIR) images (Figure 1). On the other hands,
the ADC was not changed in the lesion. Magnetic reso-
nance imaging (MR) angiography did not reveal stenosis
or the occlusion of any arteries, and T2-weighted imag-
ing showed an abnormal large vein, which indicated
DVA. The results of the blood studies, which consisted of
blood cell counts, and the results of both the biochemis-
try and coagulation studies were within the normal lim-
its. The patient’s symptom was diagnosed as a brain
infarction, and infusion therapy was initiated with oza-
grel sodium and edaravone. With the treatment, the dys-
arthria subsided in 3 days, and she had no other
neurological deficits. However, a follow-up MRI on day 7
revealed that the hyperintense lesion had increased on
DWI, and the post-gadolinium MRI on day 8 revealed an
inhomogeneous enhanced lesion. Post-gadolinium MRI
also detected DVA with the appearance of classical caput
medusae in the right frontal lobe, which drained to the
superior sagittal sinus through the cortical veins (Figure
2). The β2MG level increased to 2,061 μg/l in the CSF
study, which ruled out a malignant or degenerative dis-
ease. The patient was moved to the university hospital
for a differential diagnosis. After the patient was moved
to the hospital, the post-gadolinium MRI on day 23 dem-
onstrated the complete disappearance of the enhanced
lesions (Figure 3). MRI on day 30 did not show any
changes with DWI, but the ADC of the lesion showed an
increase. No obvious stenosis of the DVA was observed
(Figure 4). From the CSF study on day 29, the β2MG
level was 1,600 μg/l, and the myelin basic protein and
oligoclonal bands were not detected. In addition, a com-
puterized tomography scan of the body did not detect
any obvious abnormalities. She was diagnosed with
venous congestion from the course of the disease. She
has been followed for more than 5 years; she has not





Figure 1 Magnetic resonance imaging on day 1. A hyperintense area in the white matter of the right frontal lobe was detected by
fluid-attenuated inversion recovery (A) and diffusion-weighted imaging (B). The lesion was normointense on an apparent diffusion
coefficient map (C). Magnetic resonance angiography of the arterial phase did not show obvious stenosis (D).
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DISCUSSION
DVAs occur most frequently in the frontal lobe (36–
56%), followed by the parietal (12–24%), occipital (4%),
and temporal (2–19%) lobes; cerebellum (14–29%);
basal ganglia (6%); thalamus and ventricles (11%); and
brainstem (< 5%)9,21). DVAs are often difficult to identify
with routine MRI scans, because they consist mainly of
small vessels with decreased blood flow. Susceptibility-
weighted imaging is ideal for detecting small vascular
structures that are not visible via conventional images
without the use of a contrast medium12). Although it was
not performed for this patient, angiography can provide
additional information regarding the hemodynamics of




Figure 2 Magnetic resonance imaging on days 7 and 8. The hyperintense area increased in size, and new lesions appeared around
the previous lesion, as detected by fluid-attenuated inversion recovery (A) and diffusion-weighted imaging (B). The lesions were
enhanced heterogeneously, and small vessels were shown to collect and drain the dilated medullary vein (arrows) with post-
gadolinium T1-weighted imaging (C, D).
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Figure 3 Magnetic resonance imaging on day 23. The previously enhanced lesions almost disappeared. The veins had no remark-
able changes with post-gadolinium T1-weighted imaging (A, B).
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other associated pathologies, such as dural arteriovenous
shunts or arteriovenous malformations (AVMs)14).
Flow-related complications, which result from either
an increase in the inflow or a decrease in the outflow, are
estimated to account for approximately 70% of sympto-
matic DVAs14). Increased inflow is caused by micro-
shunts into DVAs or AVMs that drain into DVAs;
whereas, decreased outflow occurs due to anatomical
obstruction of the venous collector or draining sinus or
due to a functionally distant high-flow shunt. Our patient
experienced neurological deficits without signs of an
obvious AVM, arterial venous shunt, or venous/sinus
obstruction on MRI. These findings suggest that the eti-
ology of her condition is attributed to the increased
inflow of a microshunt into the DVA. On the other hand,
it may be possible that our patient had a transient
obstruction or stenosis of the draining vein and that the
condition improved following the initial treatment,
because deep cerebral venous thrombosis can lead to
extensive venous congestion and vasogenic edema with-
out early infarction6). The MRI lesion with high signal
intensity on the T2-weighted image and the post-
gadolinium MRI findings indicated the presence of vaso-
genic edema, due to destruction of the BBB. Twelve
percent of venous ischemia have been reported to be
associated with this finding8). ADC, calculated based on
the DWI, can facilitate the differential diagnosis of a
malignant tumor, because the ADC decreases with a
malignant tumor and increases with vasogenic edema
which usually occurs in the early phase of brain infarc-
tion23). However, an increased DWI intensity in brain
infarction may correspond to both an increase and a
decrease in the ADC, indicating the coexistence of vaso-
genic and cytotoxicedemas10). The interpretation of the
ADC results in patients with venous infarction requires
caution; Lövblad et al. reported 6 cases of this, 4 of
which had superficial venous thrombosis and areas of
decreased ADC, while 2 of which had deep venous
thrombosis and areas of increased ADC10).
The increases in the β2MG levels in the CSF are
believed to be local changes in the central nervous sys-
tem1). The increase in β2MG in the blood plasma or CSF
may be indicative of many different disease conditions,
such as multiple sclerosis, Neuro-Behçet’s disease, sar-
coidosis, acquired immunodeficiency syndrome-
dementia complex, meningeal metastasis of malignant
tumors, and especially, the meningeal dissemination of
acute leukemia and malignant lymphoma1). β2MG is not
specific for the diagnosis of such diseases, but elevation





Figure 4 Magnetic resonance imaging on day 30. The hyperintense area in the white matter of the right frontal lobe decreased in
size on diffusion-weighted imaging (A) but could be detected using an apparent diffusion coefficient map (B). Susceptibility-
weighted imaging revealed small vessels that had collected and drained into the dilated medullary vein (C). Magnetic resonance
venography revealed a venous anomaly (arrow) without obvious stenosis (D).
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gadolinium-enhanced lesion, served as a great marker
for the diagnosis of central nervous system lymphoma18).
Alternatively, Terent et al. reported that patients with
infarction had increased β2MG levels. In these patients,
the levels of β2MG gradually increased and peaked on
day 4 or 5 after the infarct, and then, they remained ele-
vated even 2 weeks after the onset of symptoms, as was
observed with our patient19). Considering the existence of
such cases, we had to consider the early indication of 18F
fluorodeoxyglucose or 11C methionine positron emission
tomography for the differential diagnosis of a malignant
tumor4). A cerebral perfusion assessment with MR perfu-
sion imaging may also help to differentiate cerebral
infarction and malignant lymphoma, because the
regional cerebral blood volume is moderately increased
in malignant lymphoma3).
The therapies used to treat a thrombosis related to
symptomatic DVA vary widely from serial observations
to anticoagulation therapy13). Patel et al. reported 31
cases of spontaneous thrombosis related to DVA; in
these cases, the average age of the patient was 27.9, and
there appeared to be no predilection for sex. Several
instances of DVA-related thrombosis have been reported
in patients with conditions or habits, including the Fac-
tor V Leiden mutation, smoking, and oral contraceptive
use, that make them susceptible to hypercoagulabili-
ties17,20). Therefore, a laboratory workup is required for
the examination of procoagulation factors or prothrom-
botic conditions7). When DVA is thrombosed, congestive
edema with the breakdown of the BBB is a potential con-
sequence that can lead to a hemorrhage or a true ische-
mic transformation14), though early recanalization of the
venous collector will most likely prevent this complica-
tion23). Thus, anticoagulation has been suggested as the
first-line treatment in patients with symptomatic DVA,
regardless of the presence of a hemorrhage2,11). The prog-
nosis appears to generally be good, with 73% of the cases
having a good or complete recovery and 83% experienc-
ing some form of improvement13).
CONCLUSION
The elevation of β2MG in CSF, accompanied by
gadolinium-enhanced lesions in MRI, often indicates the
presence of a malignant tumor. However, careful evalua-
tion is required when considering the associated pathol-
ogies and the potential complications of DVA, if it is
detected near a gadolinium-enhanced lesion.
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